A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Satranidazole | CAS 56302-13-7 - Request Quote

Picture of Satranidazole

Satranidazole

SZ CAT No:SZ-S095001
CAS No
56302-13-7
Mol.F.
C8H11N5O5S
Mol.Wt.
289.3
Inv. Status
Synthesis on demand
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Satranidazole is chemically 1-(1-Methyl-5-nitro-1H-imidazol-2-yl)-3-(methylsulfonyl)imidazolidin-2-one. Satranidazole is supplied with detailed characterization data compliant with regulatory guideline. Satranidazole can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Satranidazole.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 56302-13-7

Purchase 56302-13-7

Order 56302-13-7

Enquire 56302-13-7

price of 56302-13-7

56302-13-7 Supplier

56302-13-7 Manufacturer

56302-13-7 Exporter

buy high quality Satranidazole

Purchase Satranidazole

Satranidazole suppliers

Satranidazole manufacturers

Satranidazole price

Order Satranidazole

Enquire Satranidazole

Satranidazole cost

Satranidazole Supplier

Satranidazole Distributor

Satranidazole for Method Validation

Satranidazole Reference Standard

Satranidazole for ANDA Filing

Satranidazole for Forced Degradation Studies

Satranidazole Identification Standards

Satranidazole for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,